Contraception UpdateEmergency Contraception Review Evidence-based Recommendations for CliniciansCLELAND, KELLY MPA, MPH*; RAYMOND, ELIZABETH G. MD, MPH†; WESTLEY, ELIZABETH MPH‡; TRUSSELL, JAMES PhD* Author Information *Office of Population Research, Princeton University, Princeton, New Jersey †Gynuity Health Projects ‡Family Care International, New York, New York Supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development, Grant #2R24HD047879 (K.C. and J.T.). The authors declare that they have nothing to disclose. Correspondence: Kelly Cleland, MPA, MPH, 218 Wallace Hall, Princeton University, Princeton, NJ. E-mail: [email protected] Clinical Obstetrics and Gynecology: December 2014 - Volume 57 - Issue 4 - p 741-750 doi: 10.1097/GRF.0000000000000056 Buy Metrics Abstract Several options for emergency contraception are available in the United States. This article describes each method, including efficacy, mode of action, safety, side effect profile, and availability. The most effective emergency contraceptive is the copper intrauterine device (IUD), followed by ulipristal acetate and levonorgestrel pills. Levonorgestrel is available for sale without restrictions, whereas ulipristal acetate is available with prescription only, and the copper IUD must be inserted by a clinician. Although EC pills have not been shown to reduce pregnancy or abortion rates at the population level, they are an important option for individual women seeking to prevent pregnancy after sex. Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.